Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (198)	2/23/1999 7:19:00 PM
From: jeffbas	Read Replies (2) of 3158

"a market cap of $1.3 billion as a pittance" That is my view exactly in making GZMO my first decent biotech holding. Not being a scientist I had to rely on my biotech PhD daughter's view on their work. But I relied on my own expertise in assessing the value of their GENZ relationship. In my opinion, this relationship, in terms of access to management, good lawyers, top notch employees, financing, production, marketing, leading research teams and their developments, competent handling of the FDA, etc. is worth the entire present market cap EVEN IF IT WERE A STARTUP WITH NO PRODUCTS IN R&D -- which is far from the case. How's that for a non-scientist's point of view?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next